FSSNX | JSCZX | FSSNX / JSCZX | |
Total Expense Ratio | 0.03 | 1.49 | 2% |
Annual Report Gross Expense Ratio | 0.03 | 1.49 | 2% |
Fund Existence | 14 years | 13 years | - |
Gain YTD | -7.948 | -8.914 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.2B | 892M | 2,713% |
Annual Yield % from dividends | 1.13 | 0.00 | - |
Returns for 1 year | -0.02 | -13.13 | 0% |
Returns for 3 years | 2.50 | -12.06 | -21% |
Returns for 5 years | 103.11 | 40.48 | 255% |
Returns for 10 years | 58.34 | -10.85 | -538% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JETD | 20.08 | 4.21 | +26.52% |
MAX Airlines -3X Inverse Leveraged ETN | |||
THW | 11.26 | -0.01 | -0.09% |
abrdn World Healthcare Fund | |||
IBHI | 22.83 | -0.36 | -1.55% |
iShares iBonds 2029 Term HY & Inc ETF | |||
FMED | 22.95 | -0.62 | -2.62% |
Fidelity Disruptive Medicine ETF | |||
ESML | 36.53 | -2.70 | -6.88% |
iShares ESG Aware MSCI USA Small-Cap ETF |